Receptor-Targeted Research Peptides

Browse CJC-1295 5 mg + Ipamorelin 5 mg Blend and ARA-290 10 mg for their listed presentations, current prices and availability. This category organises materials through receptor-related research context. A receptor name describes part of an experimental question; it does not establish a personal effect, a clinical indication or the activity of a supplied lot. Research use only; not for human or veterinary use.

Identify the material before the mechanism

The CJC/ipamorelin comparison addresses the two-component product. The ARA-290 research lineage separates earlier receptor-model work from later peptide experiments.

Read selectivity in context

Use receptor agonists and selectivity to distinguish binding, potency and response. Use half-life modification when a research result depends on a chemically modified construct. Neither guide supplies a personal-use schedule.

For the MT-1 10 mg and MT-2 10 mg listings, use the complete research catalogue. Their technical identities and classification still need to be resolved against the product specification and lot documentation. They are not included in this category’s product selection.

Check the product's own evidence

Open the product record for its presentation and request its specification and available lot evidence through batch documentation. Confirm both components of a blend and the exact CJC variant. Buyer eligibility governs supply independently of category placement.

Supporting checks